Literature DB >> 6018457

The nature of the alpha-methyldopa red-cell antibody.

A F LoBuglio, J H Jandl.   

Abstract

Mesh:

Substances:

Year:  1967        PMID: 6018457     DOI: 10.1056/NEJM196703232761203

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  17 in total

Review 1.  Immunotoxic side-effects of drug therapy.

Authors:  J A Mitchell; E M Gillam; L A Stanley; E Sim
Journal:  Drug Saf       Date:  1990 May-Jun       Impact factor: 5.606

2.  L.E. cells and positive direct Coombs' test induced by methyldopa.

Authors:  M Harth
Journal:  Can Med Assoc J       Date:  1968-08-10       Impact factor: 8.262

3.  [Pharmacokinetics of alpha-methyldopa in kidney failure].

Authors:  K Schrader; H Brass; D Renner
Journal:  Klin Wochenschr       Date:  1971-12-15

4.  [Causes and significance of positive direct Coombs' test with special consideration of alpha methyldopa].

Authors:  W Spielmann
Journal:  Klin Wochenschr       Date:  1969-03-15

5.  Some aspects of the long-term treatment of severe hypertension with methyldopa.

Authors:  M Hamilton
Journal:  Postgrad Med J       Date:  1968-01       Impact factor: 2.401

6.  Autoimmune haemolytic anaemic complicating methyldopa therapy.

Authors:  I Surveyor; B Evans; K C Saunders; T E Parry
Journal:  Postgrad Med J       Date:  1968-06       Impact factor: 2.401

7.  Natural antibodies to procaine amide.

Authors:  A S Russell; M Ziff
Journal:  Clin Exp Immunol       Date:  1968-11       Impact factor: 4.330

8.  Drug-induced thrombocytopenia.

Authors:  P J Handagama; B F Feldman
Journal:  Vet Res Commun       Date:  1986-01       Impact factor: 2.459

9.  Lysosomes in disease.

Authors:  R K Chandra
Journal:  Indian J Pediatr       Date:  1967-12       Impact factor: 1.967

10.  Ultrastructural mapping of methyldopa and anti-D IgG erythrocyte antigen receptors.

Authors:  S P Masouredis; E Sudora
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.